Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer
暂无分享,去创建一个
TaeJin Ahn | Kyunghee Park | Jeong Eon Lee | Seok Jin Nam | J. Lee | J. Ahn | Yeon-Hee Park | T. Ahn | Y. Im | Duk-Hwan Kim | J. Lee | Kyunghee Park | S. Lim | H. Kim | K. Yoo | K. S. Jung | Haa-Na Song | M. Hong | I. Do | Se Kyung Lee | S. Bae | S. Kim | S. Nam | Hae Hyun Jung | Ji-yeon Kim | Duk-Hwan Kim | Jin Seok Ahn | Yeon Hee Park | Young-Hyuck Im | Ji-Yeon Kim | Seok Won Kim | Mineui Hong | In-Gu Do | Soo Youn Bae | Ji Yun Lee | Sung Hee Lim | Hae Su Kim | Kwai Han Yoo | Ki Sun Jung | Haa-Na Song | Jeong-Eon Lee | Duk-Hwan Kim | K. Jung
[1] Takeo Iwama,et al. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis , 1999, Oncogene.
[2] M. Nowak,et al. Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer , 2010, Nature.
[3] Ryan D. Morin,et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution , 2009, Nature.
[4] W. Gerald,et al. Genes that mediate breast cancer metastasis to the brain , 2009, Nature.
[5] A. Thompson,et al. High frequency of complex TP53 mutations in CNS metastases from breast cancer , 2011, British Journal of Cancer.
[6] J. Levine,et al. Surfing the p53 network , 2000, Nature.
[7] Paula D. Bos,et al. Metastasis: from dissemination to organ-specific colonization , 2009, Nature Reviews Cancer.
[8] J. Sage,et al. Cellular mechanisms of tumour suppression by the retinoblastoma gene , 2008, Nature Reviews Cancer.
[9] I. Fidler,et al. The brain microenvironment and cancer metastasis , 2010, Molecules and cells.
[10] M. Berger,et al. Gamma Knife radiosurgery for brain metastases from primary breast cancer. , 2007, International journal of radiation oncology, biology, physics.
[11] E. Winer,et al. CNS metastases in breast cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Raymond R Tubbs,et al. Breast Cancers With Brain Metastases are More Likely to be Estrogen Receptor Negative, Express the Basal Cytokeratin CK5/6, and Overexpress HER2 or EGFR , 2006, The American journal of surgical pathology.
[13] J. Bergh,et al. The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.
[14] Cheng Li,et al. Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.
[15] Ajit Varki,et al. Molecular basis of metastasis. , 2009, The New England journal of medicine.
[16] F. Geara,et al. Complete Response of Brain Metastases from Breast Cancer Overexpressing HER‐2/neu to Radiation and Concurrent Lapatinib and Capecitabine , 2010, The breast journal.
[17] A. Vortmeyer,et al. Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization , 2008, Clinical & Experimental Metastasis.
[18] E. Lander,et al. A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.
[19] K. Knudsen,et al. Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells. , 2007, Cancer research.
[20] I. Macdonald,et al. Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.
[21] Toshio Kuroki,et al. Role of Smad4 (DPC4) inactivation in human cancer. , 2003, Biochemical and biophysical research communications.
[22] C Caldas,et al. Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis , 1999, British Journal of Cancer.
[23] Joshua F. McMichael,et al. Genome Remodeling in a Basal-like Breast Cancer Metastasis and Xenograft , 2010, Nature.
[24] Andy J. Minn,et al. Genes that mediate breast cancer metastasis to lung , 2005, Nature.
[25] Cyrus Chargari,et al. Whole-brain radiation therapy in breast cancer patients with brain metastases , 2010, Nature Reviews Clinical Oncology.
[26] A. Maitra,et al. Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease. , 2000, The American journal of pathology.
[27] A. Stan,et al. Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer , 2007, Modern Pathology.
[28] Insuk Sohn,et al. Gradient lasso for Cox proportional hazards model , 2009, Bioinform..
[29] A. Levine,et al. Surfing the p53 network , 2000, Nature.
[30] P. ten Dijke,et al. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. , 2006, Cancer research.
[31] Chaosu Hu,et al. Survival benefit of anti-HER2 therapy after whole-brain radiotherapy in HER2-positive breast cancer patients with brain metastasis , 2016, Breast Cancer.
[32] D. Easton,et al. Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival , 2007, Breast Cancer Research.
[33] David Piwnica-Worms,et al. Contribution of p53 to metastasis. , 2014, Cancer discovery.
[34] Suyun Huang,et al. Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice , 2004, Clinical & Experimental Metastasis.
[35] F. André,et al. Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastases. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[36] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[37] P. Nederlof,et al. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer. , 2009, Cancer research.
[38] Stephen Fox,et al. HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer , 2010, Breast Cancer Research.
[39] A. Nobel,et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumours , 2013 .
[41] A. Hart,et al. Brain metastases in breast cancer; natural history, prognostic factors and outcome , 1993, Journal of Neuro-Oncology.
[42] G. Stoica,et al. MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2 , 2007, Clinical & Experimental Metastasis.
[43] T. Seike,et al. Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis , 2010, Clinical & Experimental Metastasis.
[44] Z. Weng,et al. A Global Map of p53 Transcription-Factor Binding Sites in the Human Genome , 2006, Cell.
[45] A. Kruger,et al. Cytogenomic profiling of breast cancer brain metastases reveals potential for repurposing targeted therapeutics , 2015, Oncotarget.
[46] R. Sawaya,et al. Management of brain metastases: the indispensable role of surgery , 2009, Journal of Neuro-Oncology.
[47] C. Sherr. Cancer Cell Cycles , 1996, Science.
[48] S. Hilsenbeck,et al. Primary breast cancer phenotypes associated with propensity for central nervous system metastases , 2006, Cancer.
[49] J. Pearson,et al. Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance , 2015, The Journal of pathology.